首页> 美国卫生研究院文献>Proceedings of the National Academy of Sciences of the United States of America >miR-34a directly targets tRNAiMet precursors and affects cellular proliferation cell cycle and apoptosis
【2h】

miR-34a directly targets tRNAiMet precursors and affects cellular proliferation cell cycle and apoptosis

机译:miR-34a直接靶向tRNAiMet前体并影响细胞增殖细胞周期和凋亡

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

It remains unknown whether microRNA (miRNA/miR) can target transfer RNA (tRNA) molecules. Here we provide evidence that miR-34a physically interacts with and functionally targets tRNAiMet precursors in both in vitro pulldown and Argonaute 2 (AGO2) cleavage assays. We find that miR-34a suppresses breast carcinogenesis, at least in part by lowering the levels of tRNAiMet through AGO2-mediated repression, consequently inhibiting the proliferation of breast cancer cells and inducing cell cycle arrest and apoptosis. Moreover, miR-34a expression is negatively correlated with tRNAiMet levels in cancer cell lines. Furthermore, we find that tRNAiMet knockdown also reduces cell proliferation while inducing cell cycle arrest and apoptosis. Conversely, ectopic expression of tRNAiMet promotes cell proliferation, inhibits apoptosis, and accelerates the S/G2 transition. Moreover, the enforced expression of modified tRNAiMet completely restores the phenotypic changes induced by miR-34a. Our results demonstrate that miR-34a directly targets tRNAiMet precursors via AGO2-mediated cleavage, and that tRNAiMet functions as an oncogene, potentially representing a target molecule for therapeutic intervention.
机译:microRNA(miRNA / miR)是否可以靶向转移RNA(tRNA)分子仍然是未知的。在这里,我们提供的证据表明,miR-34a在体外下拉法和Argonaute 2(AGO2)裂解试验中均与tRNAi Met 前体发生物理相互作用并功能性靶向。我们发现miR-34a抑制乳腺癌的发生,至少部分是通过AGO2介导的阻遏作用降低tRNAi Met 的水平,从而抑制了乳腺癌细胞的增殖并诱导了细胞周期停滞和凋亡。而且,miR-34a的表达与癌细胞株中tRNAi Met 的水平呈负相关。此外,我们发现,tRNAi Met 的敲除还减少细胞增殖,同时诱导细胞周期停滞和凋亡。相反,异位表达的tRNAi Met 促进细胞增殖,抑制细胞凋亡,并加速S / G2转变。而且,修饰的tRNAi Met 的强制表达完全恢复了miR-34a诱导的表型变化。我们的结果表明,miR-34a通过AGO2介导的裂解直接靶向tRNAi Met 前体,而tRNAi Met 作为癌基因起作用,可能代表了治疗干预的靶分子。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号